(Q48298914)

10 February 2018

review article

1 reference

title

Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. (English)

1 reference

10 February 2018

author name string

Grilli M

series ordinal

1

1 reference

10 February 2018

Memo M

series ordinal

2

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

10 February 2018

published in

Biochemical Pharmacology

1 reference

10 February 2018

volume

57

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

1-7

1 reference

10 February 2018

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

The NF-kappa B and I kappa B proteins: new discoveries and insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Brain synapses contain inducible forms of the transcription factor NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Constitutive NF-kappa B activity in neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Gene expression of the transcription factor NF-kappa B in hippocampus: regulation by synaptic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Presence of NF-kappaB-like and IkappaB-like immunoreactivities in postsynaptic densities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

A mu-receptor opioid agonist induces AP-1 and NF-kappa B transcription factor activity in primary cultures of rat cortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Regulation of NF-kappa B activity in rat dorsal root ganglia and PC12 cells by tumour necrosis factor and nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Increased cortical nuclear factor-kappa B (NF-kappa B) DNA binding activity after traumatic brain injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Alteration of Transcription Factor Binding Activities in the Ischemic Rat-Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Nuclear factor-kappa B in rat brain: enhanced DNA-binding activity following convulsant-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Transcriptional pharmacology of neurodegenerative disorders: novel venue towards neuroprotection against excitotoxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Janus faces of NF-kappa B: neurodestruction versus neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Activate NF-kappa B or die?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

An HMG-like protein that can switch a transcriptional activator to a repressor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Inhibition of NF-kappa B by sodium salicylate and aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Cytokine-modulating activity of tepoxalin, a new potential antirheumatic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Interferon regulatory factor-2 physically interacts with NF-kappa B in vitro and inhibits NF-kappa B induction of major histocompatibility class I and beta 2-microglobulin gene expression in transfected human neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

(-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Inhibition of NF-kappaB DNA binding by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900214-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(98)00214-7

1 reference

10 February 2018

1 reference

10 February 2018